{
"odata.metadata":"http://open.statswales.gov.wales/en-gb/dataset/$metadata#hlth0538","value":[
{
"Data":126513.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000000","PartitionKey":""
},{
"Data":119623.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000001","PartitionKey":""
},{
"Data":15043.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000002","PartitionKey":""
},{
"Data":116006.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000003","PartitionKey":""
},{
"Data":114327.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000004","PartitionKey":""
},{
"Data":27212.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000005","PartitionKey":""
},{
"Data":20182.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000006","PartitionKey":""
},{
"Data":47410.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000007","PartitionKey":""
},{
"Data":663.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000008","PartitionKey":""
},{
"Data":15738.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000009","PartitionKey":""
},{
"Data":12058.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000010","PartitionKey":""
},{
"Data":12659.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000011","PartitionKey":""
},{
"Data":6292.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000012","PartitionKey":""
},{
"Data":47410.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000013","PartitionKey":""
},{
"Data":53275.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000014","PartitionKey":""
},{
"Data":59201.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000015","PartitionKey":""
},{
"Data":49862.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000016","PartitionKey":""
},{
"Data":53414.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000017","PartitionKey":""
},{
"Data":48841.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000018","PartitionKey":""
},{
"Data":49968.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000019","PartitionKey":""
},{
"Data":47799.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000020","PartitionKey":""
},{
"Data":6395.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000021","PartitionKey":""
},{
"Data":119623.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000022","PartitionKey":""
},{
"Data":116006.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000023","PartitionKey":""
},{
"Data":115344.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000024","PartitionKey":""
},{
"Data":126513.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000025","PartitionKey":""
},{
"Data":139264.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000026","PartitionKey":""
},{
"Data":114327.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000027","PartitionKey":""
},{
"Data":125095.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000028","PartitionKey":""
},{
"Data":15043.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000029","PartitionKey":""
},{
"Data":611.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000030","PartitionKey":""
},{
"Data":969.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000031","PartitionKey":""
},{
"Data":833.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000032","PartitionKey":""
},{
"Data":446.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000033","PartitionKey":""
},{
"Data":819.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000034","PartitionKey":""
},{
"Data":921.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000035","PartitionKey":""
},{
"Data":773.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000036","PartitionKey":""
},{
"Data":848.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000037","PartitionKey":""
},{
"Data":6890.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000038","PartitionKey":""
},{
"Data":27541.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000039","PartitionKey":""
},{
"Data":27299.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000040","PartitionKey":""
},{
"Data":36269.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000041","PartitionKey":""
},{
"Data":32321.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000042","PartitionKey":""
},{
"Data":30801.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000043","PartitionKey":""
},{
"Data":31023.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000044","PartitionKey":""
},{
"Data":33553.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000045","PartitionKey":""
},{
"Data":28117.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000046","PartitionKey":""
},{
"Data":32238.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000047","PartitionKey":""
},{
"Data":33226.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000048","PartitionKey":""
},{
"Data":3464.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000049","PartitionKey":""
},{
"Data":30637.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000050","PartitionKey":""
},{
"Data":36144.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000051","PartitionKey":""
},{
"Data":29424.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000052","PartitionKey":""
},{
"Data":34201.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000053","PartitionKey":""
},{
"Data":63578.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000054","PartitionKey":""
},{
"Data":79069.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000055","PartitionKey":""
},{
"Data":66418.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000056","PartitionKey":""
},{
"Data":71380.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000057","PartitionKey":""
},{
"Data":65752.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000058","PartitionKey":""
},{
"Data":8610.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000059","PartitionKey":""
},{
"Data":70739.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000060","PartitionKey":""
},{
"Data":65084.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000061","PartitionKey":""
},{
"Data":41065.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000062","PartitionKey":""
},{
"Data":38363.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000063","PartitionKey":""
},{
"Data":2895.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000064","PartitionKey":""
},{
"Data":33276.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000065","PartitionKey":""
},{
"Data":32858.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000066","PartitionKey":""
},{
"Data":35146.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000067","PartitionKey":""
},{
"Data":36149.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000068","PartitionKey":""
},{
"Data":34217.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000069","PartitionKey":""
},{
"Data":1348.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000070","PartitionKey":""
},{
"Data":24429.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000071","PartitionKey":""
},{
"Data":21689.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000072","PartitionKey":""
},{
"Data":18599.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000073","PartitionKey":""
},{
"Data":29398.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000074","PartitionKey":""
},{
"Data":20312.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000075","PartitionKey":""
},{
"Data":24817.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000076","PartitionKey":""
},{
"Data":17260.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000077","PartitionKey":""
},{
"Data":125095.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000078","PartitionKey":""
},{
"Data":139264.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000079","PartitionKey":""
},{
"Data":115344.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"1","Outcome_ItemName_ENG":"Results reported","Outcome_SortOrder":"1","Outcome_ItemNotes_ENG":"Some patients may have been screened more than once in the year; note that in addition to known outcomes a number of results were ungradeable.","RowKey":"0000000000000080","PartitionKey":""
},{
"Data":1.295452,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000081","PartitionKey":""
},{
"Data":321.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000082","PartitionKey":""
},{
"Data":1.177176,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000083","PartitionKey":""
},{
"Data":216.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000084","PartitionKey":""
},{
"Data":1.244669,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000085","PartitionKey":""
},{
"Data":537.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000086","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000087","PartitionKey":""
},{
"Data":239.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000088","PartitionKey":""
},{
"Data":1.563215,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000089","PartitionKey":""
},{
"Data":140.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000090","PartitionKey":""
},{
"Data":1.242236,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000091","PartitionKey":""
},{
"Data":0.883759,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000092","PartitionKey":""
},{
"Data":98.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000093","PartitionKey":""
},{
"Data":1.235076,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000094","PartitionKey":""
},{
"Data":60.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000095","PartitionKey":""
},{
"Data":537.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000096","PartitionKey":""
},{
"Data":1.244669,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000097","PartitionKey":""
},{
"Data":455.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000098","PartitionKey":""
},{
"Data":0.545099,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000099","PartitionKey":""
},{
"Data":0.675937,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000100","PartitionKey":""
},{
"Data":437.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000101","PartitionKey":""
},{
"Data":462.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000102","PartitionKey":""
},{
"Data":2.424449,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000103","PartitionKey":""
},{
"Data":279.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000104","PartitionKey":""
},{
"Data":0.528017,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000105","PartitionKey":""
},{
"Data":0.519481,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000106","PartitionKey":""
},{
"Data":467.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000107","PartitionKey":""
},{
"Data":276.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000108","PartitionKey":""
},{
"Data":371.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000109","PartitionKey":""
},{
"Data":0.550911,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000110","PartitionKey":""
},{
"Data":244.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000111","PartitionKey":""
},{
"Data":288.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000112","PartitionKey":""
},{
"Data":142.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000113","PartitionKey":""
},{
"Data":0.575021,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000114","PartitionKey":""
},{
"Data":200.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000115","PartitionKey":""
},{
"Data":0.416172,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000116","PartitionKey":""
},{
"Data":0.581632,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000117","PartitionKey":""
},{
"Data":0.807819,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000118","PartitionKey":""
},{
"Data":758.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000119","PartitionKey":""
},{
"Data":980.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000120","PartitionKey":""
},{
"Data":0.625209,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000121","PartitionKey":""
},{
"Data":595.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000122","PartitionKey":""
},{
"Data":728.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000123","PartitionKey":""
},{
"Data":598.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000124","PartitionKey":""
},{
"Data":451.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000125","PartitionKey":""
},{
"Data":1108.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000126","PartitionKey":""
},{
"Data":0.610419,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000127","PartitionKey":""
},{
"Data":0.813994,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000128","PartitionKey":""
},{
"Data":0.532081,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000129","PartitionKey":""
},{
"Data":3.261498,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000130","PartitionKey":""
},{
"Data":0.527961,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000131","PartitionKey":""
},{
"Data":741.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000132","PartitionKey":""
},{
"Data":0.874524,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000133","PartitionKey":""
},{
"Data":0.604987,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000134","PartitionKey":""
},{
"Data":0.10352,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000135","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000136","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000137","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000138","PartitionKey":""
},{
"Data":1.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000139","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000140","PartitionKey":""
},{
"Data":2.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000141","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000142","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000143","PartitionKey":""
},{
"Data":1.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000144","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000145","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000146","PartitionKey":""
},{
"Data":0.236128,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000147","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000148","PartitionKey":""
},{
"Data":0.228833,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000149","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000150","PartitionKey":""
},{
"Data":1.167182,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000151","PartitionKey":""
},{
"Data":260.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000152","PartitionKey":""
},{
"Data":195.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000153","PartitionKey":""
},{
"Data":264.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000154","PartitionKey":""
},{
"Data":0.637672,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000155","PartitionKey":""
},{
"Data":0.813221,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000156","PartitionKey":""
},{
"Data":232.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000157","PartitionKey":""
},{
"Data":249.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000158","PartitionKey":""
},{
"Data":374.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000159","PartitionKey":""
},{
"Data":0.696822,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000160","PartitionKey":""
},{
"Data":0.937231,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000161","PartitionKey":""
},{
"Data":1.1696549999999999,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000162","PartitionKey":""
},{
"Data":3.956242,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000163","PartitionKey":""
},{
"Data":0.95525,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000164","PartitionKey":""
},{
"Data":337.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000165","PartitionKey":""
},{
"Data":317.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000166","PartitionKey":""
},{
"Data":3.297045,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000167","PartitionKey":""
},{
"Data":0.575511,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000168","PartitionKey":""
},{
"Data":0.631207,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000169","PartitionKey":""
},{
"Data":0.519113,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000170","PartitionKey":""
},{
"Data":0.474088,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000171","PartitionKey":""
},{
"Data":106.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000172","PartitionKey":""
},{
"Data":0.591472,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000173","PartitionKey":""
},{
"Data":172.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000174","PartitionKey":""
},{
"Data":225.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000175","PartitionKey":""
},{
"Data":0.395305,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000176","PartitionKey":""
},{
"Data":174.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000177","PartitionKey":""
},{
"Data":0.357939,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000178","PartitionKey":""
},{
"Data":129.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000179","PartitionKey":""
},{
"Data":143.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000180","PartitionKey":""
},{
"Data":160.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000181","PartitionKey":""
},{
"Data":114.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000182","PartitionKey":""
},{
"Data":307.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000183","PartitionKey":""
},{
"Data":340.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000184","PartitionKey":""
},{
"Data":0.655346,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000185","PartitionKey":""
},{
"Data":1.265585,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000186","PartitionKey":""
},{
"Data":638.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000187","PartitionKey":""
},{
"Data":0.825078,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000188","PartitionKey":""
},{
"Data":0.61744,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000189","PartitionKey":""
},{
"Data":0.660802,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000190","PartitionKey":""
},{
"Data":606.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000191","PartitionKey":""
},{
"Data":3.868448,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000192","PartitionKey":""
},{
"Data":392.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000193","PartitionKey":""
},{
"Data":113.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000194","PartitionKey":""
},{
"Data":160.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000195","PartitionKey":""
},{
"Data":0.404556,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000196","PartitionKey":""
},{
"Data":0.393512,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000197","PartitionKey":""
},{
"Data":169.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000198","PartitionKey":""
},{
"Data":59.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000199","PartitionKey":""
},{
"Data":0.452233,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000200","PartitionKey":""
},{
"Data":0.614125,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000201","PartitionKey":""
},{
"Data":0.645796,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000202","PartitionKey":""
},{
"Data":0.333836,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000203","PartitionKey":""
},{
"Data":130.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000204","PartitionKey":""
},{
"Data":0.508806,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000205","PartitionKey":""
},{
"Data":246.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000206","PartitionKey":""
},{
"Data":148.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000207","PartitionKey":""
},{
"Data":2.391569,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000208","PartitionKey":""
},{
"Data":210.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000209","PartitionKey":""
},{
"Data":0.35194,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000210","PartitionKey":""
},{
"Data":104.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000211","PartitionKey":""
},{
"Data":0.879256,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000212","PartitionKey":""
},{
"Data":222.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000213","PartitionKey":""
},{
"Data":2.027027,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000214","PartitionKey":""
},{
"Data":299.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000215","PartitionKey":""
},{
"Data":0.988626,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000216","PartitionKey":""
},{
"Data":1.350611,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000217","PartitionKey":""
},{
"Data":0.37037,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000218","PartitionKey":""
},{
"Data":1.27272,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000219","PartitionKey":""
},{
"Data":0.945219,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000220","PartitionKey":""
},{
"Data":157.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000221","PartitionKey":""
},{
"Data":181.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000222","PartitionKey":""
},{
"Data":206.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000223","PartitionKey":""
},{
"Data":79.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000224","PartitionKey":""
},{
"Data":21.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000225","PartitionKey":""
},{
"Data":728.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000226","PartitionKey":""
},{
"Data":980.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000227","PartitionKey":""
},{
"Data":1108.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000228","PartitionKey":""
},{
"Data":758.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000229","PartitionKey":""
},{
"Data":0.625209,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000230","PartitionKey":""
},{
"Data":0.532081,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000231","PartitionKey":""
},{
"Data":598.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000232","PartitionKey":""
},{
"Data":0.527961,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000233","PartitionKey":""
},{
"Data":741.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000234","PartitionKey":""
},{
"Data":0.874524,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000235","PartitionKey":""
},{
"Data":3.261498,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000236","PartitionKey":""
},{
"Data":0.813994,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000237","PartitionKey":""
},{
"Data":451.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000238","PartitionKey":""
},{
"Data":0.604987,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000239","PartitionKey":""
},{
"Data":595.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000240","PartitionKey":""
},{
"Data":0.610419,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"2","Outcome_ItemName_ENG":"Urgent referrals","Outcome_SortOrder":"2","Outcome_ItemNotes_ENG":"The \u0093Soon referral\u0094 category was not used after 26th November 2014. From then, those patients who would have been referred in the \u0093soon\u0094 category are included in the routine or urgent categories, depending on clinical need.","RowKey":"0000000000000241","PartitionKey":""
},{
"Data":76668.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000242","PartitionKey":""
},{
"Data":70.682932,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000243","PartitionKey":""
},{
"Data":71.301346,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000244","PartitionKey":""
},{
"Data":70.117242,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000245","PartitionKey":""
},{
"Data":71.781309,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000246","PartitionKey":""
},{
"Data":55.349288,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000247","PartitionKey":""
},{
"Data":13715.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000248","PartitionKey":""
},{
"Data":11169.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000249","PartitionKey":""
},{
"Data":60.869802,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000250","PartitionKey":""
},{
"Data":24898.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000251","PartitionKey":""
},{
"Data":57.709067,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000252","PartitionKey":""
},{
"Data":84.639498,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000253","PartitionKey":""
},{
"Data":540.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000254","PartitionKey":""
},{
"Data":9047.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000255","PartitionKey":""
},{
"Data":59.173262,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000256","PartitionKey":""
},{
"Data":56.947649,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000257","PartitionKey":""
},{
"Data":6418.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000258","PartitionKey":""
},{
"Data":6376.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000259","PartitionKey":""
},{
"Data":57.498422,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000260","PartitionKey":""
},{
"Data":51.811445,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000261","PartitionKey":""
},{
"Data":2517.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000262","PartitionKey":""
},{
"Data":24898.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000263","PartitionKey":""
},{
"Data":57.709067,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000264","PartitionKey":""
},{
"Data":45126.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000265","PartitionKey":""
},{
"Data":54391.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000266","PartitionKey":""
},{
"Data":3854.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000267","PartitionKey":""
},{
"Data":54.549588,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000268","PartitionKey":""
},{
"Data":72.598928,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000269","PartitionKey":""
},{
"Data":3178.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000270","PartitionKey":""
},{
"Data":42520.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000271","PartitionKey":""
},{
"Data":71.787416,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000272","PartitionKey":""
},{
"Data":73.551289,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000273","PartitionKey":""
},{
"Data":34795.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000274","PartitionKey":""
},{
"Data":38806.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000275","PartitionKey":""
},{
"Data":74.231498,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000276","PartitionKey":""
},{
"Data":54.25986,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000277","PartitionKey":""
},{
"Data":70.073038,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000278","PartitionKey":""
},{
"Data":33675.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000279","PartitionKey":""
},{
"Data":71.458378,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000280","PartitionKey":""
},{
"Data":35225.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000281","PartitionKey":""
},{
"Data":37524.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000282","PartitionKey":""
},{
"Data":33564.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000283","PartitionKey":""
},{
"Data":70.682932,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000284","PartitionKey":""
},{
"Data":70.117242,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000285","PartitionKey":""
},{
"Data":79568.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000286","PartitionKey":""
},{
"Data":72.87823,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000287","PartitionKey":""
},{
"Data":79208.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000288","PartitionKey":""
},{
"Data":85881.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000289","PartitionKey":""
},{
"Data":76668.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000290","PartitionKey":""
},{
"Data":71.301346,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000291","PartitionKey":""
},{
"Data":7054.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000292","PartitionKey":""
},{
"Data":70.248795,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000293","PartitionKey":""
},{
"Data":83024.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000294","PartitionKey":""
},{
"Data":68.560698,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000295","PartitionKey":""
},{
"Data":90498.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000296","PartitionKey":""
},{
"Data":51.012439,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000297","PartitionKey":""
},{
"Data":97708.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000298","PartitionKey":""
},{
"Data":71.781309,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000299","PartitionKey":""
},{
"Data":671.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000300","PartitionKey":""
},{
"Data":85.169029,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000301","PartitionKey":""
},{
"Data":89.344262,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000302","PartitionKey":""
},{
"Data":545.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000303","PartitionKey":""
},{
"Data":87.172775,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000304","PartitionKey":""
},{
"Data":366.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000305","PartitionKey":""
},{
"Data":666.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000306","PartitionKey":""
},{
"Data":81.081081,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000307","PartitionKey":""
},{
"Data":781.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000308","PartitionKey":""
},{
"Data":660.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000309","PartitionKey":""
},{
"Data":80.873672,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000310","PartitionKey":""
},{
"Data":685.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000311","PartitionKey":""
},{
"Data":829.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000312","PartitionKey":""
},{
"Data":85.817805,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000313","PartitionKey":""
},{
"Data":80.940893,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000314","PartitionKey":""
},{
"Data":83.75286,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000315","PartitionKey":""
},{
"Data":68.503217,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000316","PartitionKey":""
},{
"Data":24560.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000317","PartitionKey":""
},{
"Data":20975.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000318","PartitionKey":""
},{
"Data":65.056213,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000319","PartitionKey":""
},{
"Data":17837.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000320","PartitionKey":""
},{
"Data":49.258205,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000321","PartitionKey":""
},{
"Data":66.960022,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000322","PartitionKey":""
},{
"Data":3287.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000323","PartitionKey":""
},{
"Data":23164.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000324","PartitionKey":""
},{
"Data":21456.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000325","PartitionKey":""
},{
"Data":20791.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000326","PartitionKey":""
},{
"Data":69.574097,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000327","PartitionKey":""
},{
"Data":17707.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000328","PartitionKey":""
},{
"Data":65.814331,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000329","PartitionKey":""
},{
"Data":68.303807,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000330","PartitionKey":""
},{
"Data":67.988882,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000331","PartitionKey":""
},{
"Data":69.528442,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000332","PartitionKey":""
},{
"Data":73.303098,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000333","PartitionKey":""
},{
"Data":1707.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000334","PartitionKey":""
},{
"Data":23112.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000335","PartitionKey":""
},{
"Data":20641.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000336","PartitionKey":""
},{
"Data":73.234023,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000337","PartitionKey":""
},{
"Data":70.980055,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000338","PartitionKey":""
},{
"Data":23921.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000339","PartitionKey":""
},{
"Data":25212.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000340","PartitionKey":""
},{
"Data":72.567428,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000341","PartitionKey":""
},{
"Data":21893.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000342","PartitionKey":""
},{
"Data":26105.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000343","PartitionKey":""
},{
"Data":72.411854,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000344","PartitionKey":""
},{
"Data":53.094868,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000345","PartitionKey":""
},{
"Data":74.704436,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000346","PartitionKey":""
},{
"Data":19153.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000347","PartitionKey":""
},{
"Data":70.8145,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000348","PartitionKey":""
},{
"Data":73.732431,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000349","PartitionKey":""
},{
"Data":71.514785,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000350","PartitionKey":""
},{
"Data":49652.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000351","PartitionKey":""
},{
"Data":70.33986,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000352","PartitionKey":""
},{
"Data":44104.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000353","PartitionKey":""
},{
"Data":48.563508,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000354","PartitionKey":""
},{
"Data":67.370212,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000355","PartitionKey":""
},{
"Data":68.664828,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000356","PartitionKey":""
},{
"Data":42772.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000357","PartitionKey":""
},{
"Data":48113.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000358","PartitionKey":""
},{
"Data":42829.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000359","PartitionKey":""
},{
"Data":69.799384,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000360","PartitionKey":""
},{
"Data":92.107846,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000361","PartitionKey":""
},{
"Data":68.81642,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000362","PartitionKey":""
},{
"Data":24057.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000363","PartitionKey":""
},{
"Data":22786.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000364","PartitionKey":""
},{
"Data":1233.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000365","PartitionKey":""
},{
"Data":73.030322,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000366","PartitionKey":""
},{
"Data":72.656208,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000367","PartitionKey":""
},{
"Data":29535.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000368","PartitionKey":""
},{
"Data":23970.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000369","PartitionKey":""
},{
"Data":23748.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000370","PartitionKey":""
},{
"Data":74.68909,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000371","PartitionKey":""
},{
"Data":49.979732,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000372","PartitionKey":""
},{
"Data":27326.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000373","PartitionKey":""
},{
"Data":72.42812,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000374","PartitionKey":""
},{
"Data":26425.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000375","PartitionKey":""
},{
"Data":70.909317,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000376","PartitionKey":""
},{
"Data":11440.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000377","PartitionKey":""
},{
"Data":19532.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000378","PartitionKey":""
},{
"Data":461.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000379","PartitionKey":""
},{
"Data":44.498069,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000380","PartitionKey":""
},{
"Data":67.590324,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000381","PartitionKey":""
},{
"Data":70.995616,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000382","PartitionKey":""
},{
"Data":71.584201,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000383","PartitionKey":""
},{
"Data":13404.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000384","PartitionKey":""
},{
"Data":16679.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000385","PartitionKey":""
},{
"Data":12194.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000386","PartitionKey":""
},{
"Data":14916.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000387","PartitionKey":""
},{
"Data":68.290771,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000388","PartitionKey":""
},{
"Data":15172.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000389","PartitionKey":""
},{
"Data":69.599075,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000390","PartitionKey":""
},{
"Data":69.558405,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000391","PartitionKey":""
},{
"Data":69.998433,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000392","PartitionKey":""
},{
"Data":97708.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000393","PartitionKey":""
},{
"Data":83024.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000394","PartitionKey":""
},{
"Data":72.87823,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000395","PartitionKey":""
},{
"Data":68.560698,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000396","PartitionKey":""
},{
"Data":51.012439,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000397","PartitionKey":""
},{
"Data":79568.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000398","PartitionKey":""
},{
"Data":79208.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000399","PartitionKey":""
},{
"Data":90498.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000400","PartitionKey":""
},{
"Data":70.248795,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000401","PartitionKey":""
},{
"Data":85881.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000402","PartitionKey":""
},{
"Data":7054.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"3","Outcome_ItemName_ENG":"No retinopathy","Outcome_SortOrder":"3","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000403","PartitionKey":""
},{
"Data":38411.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000404","PartitionKey":""
},{
"Data":36601.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000405","PartitionKey":""
},{
"Data":35157.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000406","PartitionKey":""
},{
"Data":33417.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000407","PartitionKey":""
},{
"Data":48.987561,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000408","PartitionKey":""
},{
"Data":33679.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000409","PartitionKey":""
},{
"Data":29.751205,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000410","PartitionKey":""
},{
"Data":28.698654,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000411","PartitionKey":""
},{
"Data":33698.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000412","PartitionKey":""
},{
"Data":27.12177,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000413","PartitionKey":""
},{
"Data":29.882758,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000414","PartitionKey":""
},{
"Data":31.439302,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000415","PartitionKey":""
},{
"Data":28.218691,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000416","PartitionKey":""
},{
"Data":11064.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000417","PartitionKey":""
},{
"Data":44.650712,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000418","PartitionKey":""
},{
"Data":7180.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000419","PartitionKey":""
},{
"Data":39.130198,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000420","PartitionKey":""
},{
"Data":42.290933,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000421","PartitionKey":""
},{
"Data":18246.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000422","PartitionKey":""
},{
"Data":15.360502,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000423","PartitionKey":""
},{
"Data":98.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000424","PartitionKey":""
},{
"Data":6242.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000425","PartitionKey":""
},{
"Data":40.826738,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000426","PartitionKey":""
},{
"Data":4852.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000427","PartitionKey":""
},{
"Data":43.052351,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000428","PartitionKey":""
},{
"Data":42.501578,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000429","PartitionKey":""
},{
"Data":4713.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000430","PartitionKey":""
},{
"Data":48.188555,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000431","PartitionKey":""
},{
"Data":2341.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000432","PartitionKey":""
},{
"Data":42.290933,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000433","PartitionKey":""
},{
"Data":18246.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000434","PartitionKey":""
},{
"Data":21802.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000435","PartitionKey":""
},{
"Data":19682.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000436","PartitionKey":""
},{
"Data":31.335172,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000437","PartitionKey":""
},{
"Data":4082.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000438","PartitionKey":""
},{
"Data":30.200616,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000439","PartitionKey":""
},{
"Data":14382.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000440","PartitionKey":""
},{
"Data":2679.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000441","PartitionKey":""
},{
"Data":27.401072,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000442","PartitionKey":""
},{
"Data":13295.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000443","PartitionKey":""
},{
"Data":13471.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000444","PartitionKey":""
},{
"Data":28.212584,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000445","PartitionKey":""
},{
"Data":15290.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000446","PartitionKey":""
},{
"Data":20.518609,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000447","PartitionKey":""
},{
"Data":25.768502,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000448","PartitionKey":""
},{
"Data":29.926962,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000449","PartitionKey":""
},{
"Data":13406.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000450","PartitionKey":""
},{
"Data":26.448711,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000451","PartitionKey":""
},{
"Data":45.74014,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000452","PartitionKey":""
},{
"Data":28.541622,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000453","PartitionKey":""
},{
"Data":14747.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000454","PartitionKey":""
},{
"Data":13088.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000455","PartitionKey":""
},{
"Data":35157.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000456","PartitionKey":""
},{
"Data":28.698654,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000457","PartitionKey":""
},{
"Data":36601.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000458","PartitionKey":""
},{
"Data":28.218691,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000459","PartitionKey":""
},{
"Data":32853.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000460","PartitionKey":""
},{
"Data":33698.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000461","PartitionKey":""
},{
"Data":27.12177,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000462","PartitionKey":""
},{
"Data":48.987561,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000463","PartitionKey":""
},{
"Data":38411.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000464","PartitionKey":""
},{
"Data":6774.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000465","PartitionKey":""
},{
"Data":29.882758,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000466","PartitionKey":""
},{
"Data":33417.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000467","PartitionKey":""
},{
"Data":29.751205,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000468","PartitionKey":""
},{
"Data":31.439302,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000469","PartitionKey":""
},{
"Data":29.317068,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000470","PartitionKey":""
},{
"Data":33679.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000471","PartitionKey":""
},{
"Data":19.059107,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000472","PartitionKey":""
},{
"Data":16.24714,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000473","PartitionKey":""
},{
"Data":136.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000474","PartitionKey":""
},{
"Data":71.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000475","PartitionKey":""
},{
"Data":154.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000476","PartitionKey":""
},{
"Data":12.827225,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000477","PartitionKey":""
},{
"Data":162.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000478","PartitionKey":""
},{
"Data":18.918919,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000479","PartitionKey":""
},{
"Data":137.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000480","PartitionKey":""
},{
"Data":10.655738,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000481","PartitionKey":""
},{
"Data":14.182195,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000482","PartitionKey":""
},{
"Data":19.126328,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000483","PartitionKey":""
},{
"Data":158.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000484","PartitionKey":""
},{
"Data":65.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000485","PartitionKey":""
},{
"Data":98.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000486","PartitionKey":""
},{
"Data":14.830971,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000487","PartitionKey":""
},{
"Data":33.039978,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000488","PartitionKey":""
},{
"Data":9644.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000489","PartitionKey":""
},{
"Data":9511.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000490","PartitionKey":""
},{
"Data":50.741795,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000491","PartitionKey":""
},{
"Data":31.496783,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000492","PartitionKey":""
},{
"Data":9265.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000493","PartitionKey":""
},{
"Data":30.425903,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000494","PartitionKey":""
},{
"Data":31.696193,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000495","PartitionKey":""
},{
"Data":11397.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000496","PartitionKey":""
},{
"Data":34.943787,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000497","PartitionKey":""
},{
"Data":34.185669,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000498","PartitionKey":""
},{
"Data":3386.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000499","PartitionKey":""
},{
"Data":10587.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000500","PartitionKey":""
},{
"Data":32.011118,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000501","PartitionKey":""
},{
"Data":10130.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000502","PartitionKey":""
},{
"Data":9789.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000503","PartitionKey":""
},{
"Data":8341.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000504","PartitionKey":""
},{
"Data":26.765977,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000505","PartitionKey":""
},{
"Data":27.588146,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000506","PartitionKey":""
},{
"Data":26.696902,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000507","PartitionKey":""
},{
"Data":8537.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000508","PartitionKey":""
},{
"Data":8712.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000509","PartitionKey":""
},{
"Data":25.295564,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000510","PartitionKey":""
},{
"Data":29.019945,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000511","PartitionKey":""
},{
"Data":8394.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000512","PartitionKey":""
},{
"Data":9541.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000513","PartitionKey":""
},{
"Data":8439.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000514","PartitionKey":""
},{
"Data":8737.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000515","PartitionKey":""
},{
"Data":46.905132,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000516","PartitionKey":""
},{
"Data":30.471558,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000517","PartitionKey":""
},{
"Data":27.432572,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000518","PartitionKey":""
},{
"Data":1508.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000519","PartitionKey":""
},{
"Data":9348.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000520","PartitionKey":""
},{
"Data":20716.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000521","PartitionKey":""
},{
"Data":19777.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000522","PartitionKey":""
},{
"Data":22935.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000523","PartitionKey":""
},{
"Data":31.18358,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000524","PartitionKey":""
},{
"Data":41.104359,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000525","PartitionKey":""
},{
"Data":19525.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000526","PartitionKey":""
},{
"Data":19545.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000527","PartitionKey":""
},{
"Data":51.436492,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000528","PartitionKey":""
},{
"Data":32.629788,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000529","PartitionKey":""
},{
"Data":28.485215,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000530","PartitionKey":""
},{
"Data":29.66014,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000531","PartitionKey":""
},{
"Data":8955.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000532","PartitionKey":""
},{
"Data":9158.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000533","PartitionKey":""
},{
"Data":10522.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000534","PartitionKey":""
},{
"Data":8770.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000535","PartitionKey":""
},{
"Data":26.969678,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000536","PartitionKey":""
},{
"Data":1234.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000537","PartitionKey":""
},{
"Data":29.1855,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000538","PartitionKey":""
},{
"Data":29.090683,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000539","PartitionKey":""
},{
"Data":50.020268,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000540","PartitionKey":""
},{
"Data":26.267569,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000541","PartitionKey":""
},{
"Data":27.57188,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000542","PartitionKey":""
},{
"Data":25.31091,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000543","PartitionKey":""
},{
"Data":9879.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000544","PartitionKey":""
},{
"Data":27.343792,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000545","PartitionKey":""
},{
"Data":10284.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000546","PartitionKey":""
},{
"Data":31.709229,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000547","PartitionKey":""
},{
"Data":28.415799,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000548","PartitionKey":""
},{
"Data":30.001567,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000549","PartitionKey":""
},{
"Data":30.441595,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000550","PartitionKey":""
},{
"Data":6814.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000551","PartitionKey":""
},{
"Data":4997.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000552","PartitionKey":""
},{
"Data":5745.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000553","PartitionKey":""
},{
"Data":5662.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000554","PartitionKey":""
},{
"Data":32.409676,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000555","PartitionKey":""
},{
"Data":29.004384,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000556","PartitionKey":""
},{
"Data":7275.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000557","PartitionKey":""
},{
"Data":5921.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000558","PartitionKey":""
},{
"Data":575.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000559","PartitionKey":""
},{
"Data":8548.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000560","PartitionKey":""
},{
"Data":30.400925,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000561","PartitionKey":""
},{
"Data":55.501931,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000562","PartitionKey":""
},{
"Data":29.317068,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000563","PartitionKey":""
},{
"Data":32853.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000564","PartitionKey":""
},{
"Data":6774.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"4","Outcome_ItemName_ENG":"Any retinopathy","Outcome_SortOrder":"4","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000565","PartitionKey":""
},{
"Data":10.678397,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000566","PartitionKey":""
},{
"Data":2646.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000567","PartitionKey":""
},{
"Data":1886.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000568","PartitionKey":""
},{
"Data":10.278489,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000569","PartitionKey":""
},{
"Data":10.504358,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000570","PartitionKey":""
},{
"Data":4532.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000571","PartitionKey":""
},{
"Data":0.470219,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000572","PartitionKey":""
},{
"Data":3.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000573","PartitionKey":""
},{
"Data":10.739748,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000574","PartitionKey":""
},{
"Data":1642.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000575","PartitionKey":""
},{
"Data":10.301686,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000576","PartitionKey":""
},{
"Data":1161.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000577","PartitionKey":""
},{
"Data":9.405717,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000578","PartitionKey":""
},{
"Data":1043.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000579","PartitionKey":""
},{
"Data":14.059284,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000580","PartitionKey":""
},{
"Data":683.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000581","PartitionKey":""
},{
"Data":4532.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000582","PartitionKey":""
},{
"Data":10.504358,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000583","PartitionKey":""
},{
"Data":2068.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000584","PartitionKey":""
},{
"Data":6.200386,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000585","PartitionKey":""
},{
"Data":1473.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000586","PartitionKey":""
},{
"Data":18.560988,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000587","PartitionKey":""
},{
"Data":4.662317,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000588","PartitionKey":""
},{
"Data":3237.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000589","PartitionKey":""
},{
"Data":6.053591,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000590","PartitionKey":""
},{
"Data":3.315484,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000591","PartitionKey":""
},{
"Data":8.854917,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000592","PartitionKey":""
},{
"Data":6.530368,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000593","PartitionKey":""
},{
"Data":4.427304,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000594","PartitionKey":""
},{
"Data":5.870113,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000595","PartitionKey":""
},{
"Data":3.423331,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000596","PartitionKey":""
},{
"Data":2030.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000597","PartitionKey":""
},{
"Data":3.883161,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000598","PartitionKey":""
},{
"Data":857.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000599","PartitionKey":""
},{
"Data":5.725928,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000600","PartitionKey":""
},{
"Data":5.300121,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000601","PartitionKey":""
},{
"Data":2.663402,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000602","PartitionKey":""
},{
"Data":1251.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000603","PartitionKey":""
},{
"Data":2824.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000604","PartitionKey":""
},{
"Data":3064.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000605","PartitionKey":""
},{
"Data":1661.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000606","PartitionKey":""
},{
"Data":2993.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000607","PartitionKey":""
},{
"Data":14.632064,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000608","PartitionKey":""
},{
"Data":2821.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000609","PartitionKey":""
},{
"Data":2335.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000610","PartitionKey":""
},{
"Data":5.700159,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000611","PartitionKey":""
},{
"Data":4.273738,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000612","PartitionKey":""
},{
"Data":3.732362,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000613","PartitionKey":""
},{
"Data":5.997616,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000614","PartitionKey":""
},{
"Data":5307.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000615","PartitionKey":""
},{
"Data":7152.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000616","PartitionKey":""
},{
"Data":3369.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000617","PartitionKey":""
},{
"Data":16.886028,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000618","PartitionKey":""
},{
"Data":6.24279,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000619","PartitionKey":""
},{
"Data":7759.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000620","PartitionKey":""
},{
"Data":6981.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000621","PartitionKey":""
},{
"Data":7346.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000622","PartitionKey":""
},{
"Data":2.974414,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000623","PartitionKey":""
},{
"Data":6.382238,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000624","PartitionKey":""
},{
"Data":4346.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000625","PartitionKey":""
},{
"Data":7.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000626","PartitionKey":""
},{
"Data":0.87241,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000627","PartitionKey":""
},{
"Data":1.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000628","PartitionKey":""
},{
"Data":5.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000629","PartitionKey":""
},{
"Data":6.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000630","PartitionKey":""
},{
"Data":1.144165,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000631","PartitionKey":""
},{
"Data":8.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000632","PartitionKey":""
},{
"Data":0.737101,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000633","PartitionKey":""
},{
"Data":5.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000634","PartitionKey":""
},{
"Data":0.13089,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000635","PartitionKey":""
},{
"Data":0.517598,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000636","PartitionKey":""
},{
"Data":0.844391,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000637","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000638","PartitionKey":""
},{
"Data":0.708383,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000639","PartitionKey":""
},{
"Data":6.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000640","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000641","PartitionKey":""
},{
"Data":5.728469,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000642","PartitionKey":""
},{
"Data":16.679155,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000643","PartitionKey":""
},{
"Data":7.686959,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000644","PartitionKey":""
},{
"Data":8.719533,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000645","PartitionKey":""
},{
"Data":8.494379,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000646","PartitionKey":""
},{
"Data":1754.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000647","PartitionKey":""
},{
"Data":2312.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000648","PartitionKey":""
},{
"Data":1113.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000649","PartitionKey":""
},{
"Data":6.409563,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000650","PartitionKey":""
},{
"Data":4.682799,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000651","PartitionKey":""
},{
"Data":8.62667,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000652","PartitionKey":""
},{
"Data":2794.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000653","PartitionKey":""
},{
"Data":2764.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000654","PartitionKey":""
},{
"Data":2338.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000655","PartitionKey":""
},{
"Data":2134.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000656","PartitionKey":""
},{
"Data":1432.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000657","PartitionKey":""
},{
"Data":843.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000658","PartitionKey":""
},{
"Data":1663.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000659","PartitionKey":""
},{
"Data":5.619501,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000660","PartitionKey":""
},{
"Data":1919.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000661","PartitionKey":""
},{
"Data":1351.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000662","PartitionKey":""
},{
"Data":17.449456,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000663","PartitionKey":""
},{
"Data":4.003082,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000664","PartitionKey":""
},{
"Data":1699.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000665","PartitionKey":""
},{
"Data":5.718707,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000666","PartitionKey":""
},{
"Data":3.288083,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000667","PartitionKey":""
},{
"Data":5.383493,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000668","PartitionKey":""
},{
"Data":6.134969,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000669","PartitionKey":""
},{
"Data":1690.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000670","PartitionKey":""
},{
"Data":2.646865,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000671","PartitionKey":""
},{
"Data":561.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000672","PartitionKey":""
},{
"Data":1073.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000673","PartitionKey":""
},{
"Data":2625.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000674","PartitionKey":""
},{
"Data":4681.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000675","PartitionKey":""
},{
"Data":4.060262,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000676","PartitionKey":""
},{
"Data":4335.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000677","PartitionKey":""
},{
"Data":4240.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000678","PartitionKey":""
},{
"Data":4146.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000679","PartitionKey":""
},{
"Data":1583.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000680","PartitionKey":""
},{
"Data":4.788117,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000681","PartitionKey":""
},{
"Data":926.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000682","PartitionKey":""
},{
"Data":4.676652,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000683","PartitionKey":""
},{
"Data":434.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000684","PartitionKey":""
},{
"Data":4.331328,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000685","PartitionKey":""
},{
"Data":2.998869,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000686","PartitionKey":""
},{
"Data":1735.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000687","PartitionKey":""
},{
"Data":715.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000688","PartitionKey":""
},{
"Data":4.607817,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000689","PartitionKey":""
},{
"Data":17.592217,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000690","PartitionKey":""
},{
"Data":1733.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000691","PartitionKey":""
},{
"Data":1557.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000692","PartitionKey":""
},{
"Data":1061.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000693","PartitionKey":""
},{
"Data":2.787897,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000694","PartitionKey":""
},{
"Data":2.225058,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000695","PartitionKey":""
},{
"Data":5.740741,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000696","PartitionKey":""
},{
"Data":6.223763,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000697","PartitionKey":""
},{
"Data":3.065434,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000698","PartitionKey":""
},{
"Data":21.428571,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000699","PartitionKey":""
},{
"Data":2.088934,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000700","PartitionKey":""
},{
"Data":753.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000701","PartitionKey":""
},{
"Data":373.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000702","PartitionKey":""
},{
"Data":1336.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000703","PartitionKey":""
},{
"Data":6.214639,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000704","PartitionKey":""
},{
"Data":1023.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000705","PartitionKey":""
},{
"Data":1612.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000706","PartitionKey":""
},{
"Data":3.613764,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000707","PartitionKey":""
},{
"Data":1395.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000708","PartitionKey":""
},{
"Data":222.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000709","PartitionKey":""
},{
"Data":5.6868,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000710","PartitionKey":""
},{
"Data":587.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000711","PartitionKey":""
},{
"Data":7152.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000712","PartitionKey":""
},{
"Data":5.997616,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000713","PartitionKey":""
},{
"Data":3369.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000714","PartitionKey":""
},{
"Data":7346.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000715","PartitionKey":""
},{
"Data":7759.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000716","PartitionKey":""
},{
"Data":5307.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000717","PartitionKey":""
},{
"Data":2335.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000718","PartitionKey":""
},{
"Data":6.382238,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000719","PartitionKey":""
},{
"Data":16.886028,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000720","PartitionKey":""
},{
"Data":3.732362,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000721","PartitionKey":""
},{
"Data":4.273738,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000722","PartitionKey":""
},{
"Data":5.700159,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000723","PartitionKey":""
},{
"Data":2.974414,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000724","PartitionKey":""
},{
"Data":6.24279,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000725","PartitionKey":""
},{
"Data":4346.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000726","PartitionKey":""
},{
"Data":6981.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"5","Outcome_ItemName_ENG":"Sight threatening retinopathy/maculopathy","Outcome_SortOrder":"5","Outcome_ItemNotes_ENG":"","RowKey":"0000000000000727","PartitionKey":""
},{
"Data":1397.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000728","PartitionKey":""
},{
"Data":0.523139,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000729","PartitionKey":""
},{
"Data":3.239803,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000730","PartitionKey":""
},{
"Data":505.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000731","PartitionKey":""
},{
"Data":1.295452,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000732","PartitionKey":""
},{
"Data":321.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000733","PartitionKey":""
},{
"Data":216.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000734","PartitionKey":""
},{
"Data":1.177176,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000735","PartitionKey":""
},{
"Data":537.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000736","PartitionKey":""
},{
"Data":1.244669,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000737","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000738","PartitionKey":""
},{
"Data":1.563215,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000739","PartitionKey":""
},{
"Data":239.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000740","PartitionKey":""
},{
"Data":1.242236,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000741","PartitionKey":""
},{
"Data":140.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000742","PartitionKey":""
},{
"Data":98.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000743","PartitionKey":""
},{
"Data":0.883759,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000744","PartitionKey":""
},{
"Data":60.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000745","PartitionKey":""
},{
"Data":1.235076,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000746","PartitionKey":""
},{
"Data":537.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000747","PartitionKey":""
},{
"Data":1.244669,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2021-22","Year_ItemName_ENG":"2021-22","Year_SortOrder":"8","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000748","PartitionKey":""
},{
"Data":181.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000749","PartitionKey":""
},{
"Data":490.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000750","PartitionKey":""
},{
"Data":0.311801,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000751","PartitionKey":""
},{
"Data":0.531844,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000752","PartitionKey":""
},{
"Data":0.373042,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000753","PartitionKey":""
},{
"Data":306.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000754","PartitionKey":""
},{
"Data":173.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000755","PartitionKey":""
},{
"Data":0.768194,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000756","PartitionKey":""
},{
"Data":0.458398,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000757","PartitionKey":""
},{
"Data":265.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000758","PartitionKey":""
},{
"Data":0.393283,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000759","PartitionKey":""
},{
"Data":5.224518,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000760","PartitionKey":""
},{
"Data":0.36832,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000761","PartitionKey":""
},{
"Data":189.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000762","PartitionKey":""
},{
"Data":278.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000763","PartitionKey":""
},{
"Data":163.0,"Characteristics_Code":"F","Characteristics_ItemName_ENG":"Gender: Female","Characteristics_SortOrder":"3","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000764","PartitionKey":""
},{
"Data":562.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000765","PartitionKey":""
},{
"Data":3.239803,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000766","PartitionKey":""
},{
"Data":0.544377,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000767","PartitionKey":""
},{
"Data":0.614784,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000768","PartitionKey":""
},{
"Data":0.523139,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000769","PartitionKey":""
},{
"Data":505.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000770","PartitionKey":""
},{
"Data":448.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000771","PartitionKey":""
},{
"Data":1.246642,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000772","PartitionKey":""
},{
"Data":0.482648,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000773","PartitionKey":""
},{
"Data":753.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000774","PartitionKey":""
},{
"Data":0.390572,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000775","PartitionKey":""
},{
"Data":1397.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000776","PartitionKey":""
},{
"Data":741.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000777","PartitionKey":""
},{
"Data":485.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000778","PartitionKey":""
},{
"Data":585.0,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000779","PartitionKey":""
},{
"Data":0.445853,"Characteristics_Code":"GT","Characteristics_ItemName_ENG":"Gender: Total","Characteristics_SortOrder":"1","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes unspecified gender figures","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000780","PartitionKey":""
},{
"Data":0.118064,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000781","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000782","PartitionKey":""
},{
"Data":0.10352,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000783","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000784","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000785","PartitionKey":""
},{
"Data":1.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000786","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000787","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000788","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000789","PartitionKey":""
},{
"Data":1.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000790","PartitionKey":""
},{
"Data":0.228833,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000791","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000792","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000793","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000794","PartitionKey":""
},{
"Data":0.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000795","PartitionKey":""
},{
"Data":1.0,"Characteristics_Code":"1","Characteristics_ItemName_ENG":"Age: 19 years and under","Characteristics_SortOrder":"5","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000796","PartitionKey":""
},{
"Data":211.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000797","PartitionKey":""
},{
"Data":260.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000798","PartitionKey":""
},{
"Data":3.941256,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000799","PartitionKey":""
},{
"Data":0.830608,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000800","PartitionKey":""
},{
"Data":0.885071,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000801","PartitionKey":""
},{
"Data":254.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000802","PartitionKey":""
},{
"Data":1.853759,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000803","PartitionKey":""
},{
"Data":594.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000804","PartitionKey":""
},{
"Data":323.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000805","PartitionKey":""
},{
"Data":271.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000806","PartitionKey":""
},{
"Data":0.633748,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000807","PartitionKey":""
},{
"Data":0.898295,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000808","PartitionKey":""
},{
"Data":1.184414,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000809","PartitionKey":""
},{
"Data":263.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000810","PartitionKey":""
},{
"Data":321.0,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000811","PartitionKey":""
},{
"Data":0.95525,"Characteristics_Code":"2","Characteristics_ItemName_ENG":"Age: 20-59 years","Characteristics_SortOrder":"6","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000812","PartitionKey":""
},{
"Data":131.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000813","PartitionKey":""
},{
"Data":0.504965,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000814","PartitionKey":""
},{
"Data":3.265941,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000815","PartitionKey":""
},{
"Data":105.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000816","PartitionKey":""
},{
"Data":1.008798,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000817","PartitionKey":""
},{
"Data":0.383058,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000818","PartitionKey":""
},{
"Data":0.364662,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000819","PartitionKey":""
},{
"Data":180.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000820","PartitionKey":""
},{
"Data":119.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000821","PartitionKey":""
},{
"Data":0.511852,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000822","PartitionKey":""
},{
"Data":0.38816,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000823","PartitionKey":""
},{
"Data":0.612105,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000824","PartitionKey":""
},{
"Data":178.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000825","PartitionKey":""
},{
"Data":141.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000826","PartitionKey":""
},{
"Data":122.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000827","PartitionKey":""
},{
"Data":305.0,"Characteristics_Code":"3","Characteristics_ItemName_ENG":"Age: 60-69 years","Characteristics_SortOrder":"7","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000828","PartitionKey":""
},{
"Data":326.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000829","PartitionKey":""
},{
"Data":1.764113,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000830","PartitionKey":""
},{
"Data":321.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000831","PartitionKey":""
},{
"Data":472.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000832","PartitionKey":""
},{
"Data":314.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000833","PartitionKey":""
},{
"Data":393.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000834","PartitionKey":""
},{
"Data":0.514638,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000835","PartitionKey":""
},{
"Data":1.839901,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000836","PartitionKey":""
},{
"Data":0.611696,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000837","PartitionKey":""
},{
"Data":373.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000838","PartitionKey":""
},{
"Data":473.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000839","PartitionKey":""
},{
"Data":140.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000840","PartitionKey":""
},{
"Data":0.619015,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000841","PartitionKey":""
},{
"Data":0.452261,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000842","PartitionKey":""
},{
"Data":0.675105,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000843","PartitionKey":""
},{
"Data":881.0,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000844","PartitionKey":""
},{
"Data":0.576944,"Characteristics_Code":"M","Characteristics_ItemName_ENG":"Gender: Male","Characteristics_SortOrder":"2","Characteristics_Hierarchy":"GT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000845","PartitionKey":""
},{
"Data":81.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000846","PartitionKey":""
},{
"Data":58.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000847","PartitionKey":""
},{
"Data":0.252069,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000848","PartitionKey":""
},{
"Data":81.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000849","PartitionKey":""
},{
"Data":0.33702,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000850","PartitionKey":""
},{
"Data":0.322018,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000851","PartitionKey":""
},{
"Data":0.404148,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000852","PartitionKey":""
},{
"Data":0.228943,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000853","PartitionKey":""
},{
"Data":135.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000854","PartitionKey":""
},{
"Data":116.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000855","PartitionKey":""
},{
"Data":109.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000856","PartitionKey":""
},{
"Data":1.002522,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000857","PartitionKey":""
},{
"Data":2.351034,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000858","PartitionKey":""
},{
"Data":0.34924,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000859","PartitionKey":""
},{
"Data":152.0,"Characteristics_Code":"4","Characteristics_ItemName_ENG":"Age: 70-79 years","Characteristics_SortOrder":"8","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000860","PartitionKey":""
},{
"Data":62.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000861","PartitionKey":""
},{
"Data":56.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000862","PartitionKey":""
},{
"Data":0.33412,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000863","PartitionKey":""
},{
"Data":0.297548,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000864","PartitionKey":""
},{
"Data":0.363248,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000865","PartitionKey":""
},{
"Data":0.292443,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000866","PartitionKey":""
},{
"Data":102.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000867","PartitionKey":""
},{
"Data":0.434172,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000868","PartitionKey":""
},{
"Data":47.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000869","PartitionKey":""
},{
"Data":21.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000870","PartitionKey":""
},{
"Data":0.263217,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000871","PartitionKey":""
},{
"Data":152.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000872","PartitionKey":""
},{
"Data":2.027027,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000873","PartitionKey":""
},{
"Data":75.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000874","PartitionKey":""
},{
"Data":0.924743,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000875","PartitionKey":""
},{
"Data":102.0,"Characteristics_Code":"5","Characteristics_ItemName_ENG":"Age: 80 years or over","Characteristics_SortOrder":"9","Characteristics_Hierarchy":"AT","Characteristics_ItemNotes_ENG":"","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000876","PartitionKey":""
},{
"Data":0.390572,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000877","PartitionKey":""
},{
"Data":1.246642,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2017-18","Year_ItemName_ENG":"2017-18","Year_SortOrder":"4","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000878","PartitionKey":""
},{
"Data":741.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000879","PartitionKey":""
},{
"Data":0.445853,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2013-14","Year_ItemName_ENG":"2013-14","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000880","PartitionKey":""
},{
"Data":562.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000881","PartitionKey":""
},{
"Data":585.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2019-20","Year_ItemName_ENG":"2019-20","Year_SortOrder":"6","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000882","PartitionKey":""
},{
"Data":753.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000883","PartitionKey":""
},{
"Data":0.544377,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2016-17","Year_ItemName_ENG":"2016-17","Year_SortOrder":"3","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000884","PartitionKey":""
},{
"Data":0.614784,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2018-19","Year_ItemName_ENG":"2018-19","Year_SortOrder":"5","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000885","PartitionKey":""
},{
"Data":485.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2015-16","Year_ItemName_ENG":"2015-16","Year_SortOrder":"2","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000886","PartitionKey":""
},{
"Data":0.482648,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2014-15","Year_ItemName_ENG":"2014-15","Year_SortOrder":"1","Year_ItemNotes_ENG":"","Measure_Code":"M2","Measure_ItemName_ENG":"Percentage of results reported","Measure_SortOrder":"2","Measure_ItemNotes_ENG":"A small number of outcomes are ungradeable; percentages are calculated on the basis of excluding ungradeable outcomes from the total","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000887","PartitionKey":""
},{
"Data":448.0,"Characteristics_Code":"AT","Characteristics_ItemName_ENG":"Age: Total","Characteristics_SortOrder":"4","Characteristics_Hierarchy":"","Characteristics_ItemNotes_ENG":"Total includes a small number of patients where the characteristic is not recorded.","Year_Code":"2020-21","Year_ItemName_ENG":"2020-21","Year_SortOrder":"7","Year_ItemNotes_ENG":"","Measure_Code":"M1","Measure_ItemName_ENG":"Number","Measure_SortOrder":"1","Measure_ItemNotes_ENG":"","Outcome_Code":"6","Outcome_ItemName_ENG":"Severe retinopathy/maculopathy","Outcome_SortOrder":"6","Outcome_ItemNotes_ENG":"Number of people with sight threatening retinopathy/maculopathy that is severe \u0096 note, these patients appear in both the sight threatening and severe categories.","RowKey":"0000000000000888","PartitionKey":""
}
]
}